Company intelligence / Profile preview

Humacology

Australia

Ownership: Private
Development stage: Other

Overview

Humacology conducts clinical trials with two of its medicines; specific clinical outcomes are not disclosed publicly. The company provides pharmaceutical-grade, high-quality medicinal cannabis and CBD therapies supplied to Australian patients

Therapeutic areas: OtherNeurology
Modalities: Small moleculePhytochemical (Cannabinoid)
Industry: Biotech

Partnerships

Cana (manufacturing partner; Cosmos Health)potential partnerships for clinical trials (details not public)

Beyond the preview

Go deeper on Humacology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Humacology.

Explore the full profile